Dmitriy Genkin

Président chez PHARMSYNTHEZ Fortune : 215 662 $ au 31/05/2026

Profil

Dr. Dmitriy D.
Genkin, MD, is an Executive Chairman at Pharmsynthez PJSC, a Managing Director at FDS Pharma LLP and a Director & Partner at FDS Pharma Associates Ltd. He is on the Board of Directors at Kevelt AS, SynBio LLC, EPhaG AS, CLS Therapeutics, Inc., Peri-Ness Technologies Ltd., Santersus AG, FDS Pharma Associates Ltd. and Xenetic Biosciences, Inc. Dr. Genkin was previously employed as a Non-Executive Director by Xenetic Biosciences, Inc., a Non-Executive Director by Human Stem Cells Institute OJSC, a Non-Executive Director by Xenetic Biosciences, Inc., and a Professor by University College London.
He also served on the board at Xenetic Biosciences Plc.
He received his undergraduate degree from Mechnikov St Petersburg State Medical Academy and a graduate degree from The School of Pharmacy University of London.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
XENETIC BIOSCIENCES, INC. 2,99%	15/10/2025	68 464 ( 2,99% )	215 662 $	31/05/2026

Postes actifs de Dmitriy Genkin

Sociétés	Poste	Début
PHARMSYNTHEZ	Président	01/01/2005
XENETIC BIOSCIENCES, INC.	Directeur/Membre du Conseil	-
Peri-Ness Technologies Ltd.	Directeur/Membre du Conseil	-
SANTERSUS AG	Fondateur	-
SynBio LLC	Directeur/Membre du Conseil	01/01/2011
Kevelt AS	Directeur/Membre du Conseil	01/01/2013
FDS Pharma LLP	Directeur Général	01/01/2003
EPhaG AS	Directeur/Membre du Conseil	01/01/2007
FDS Pharma Associates Ltd.	Directeur/Membre du Conseil	17/11/2010
░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-

Anciens postes connus de Dmitriy Genkin

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░ ░░░░░ ░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-